Scalable hiPSC Platform for ASO Efficacy and Toxicity Screening
hiPSC-Derived Neurons and Microglia: In Vitro Neuroinflammation
MCL1 Inhibitor Cardiotoxicity Assessment Using iPSC-Derived Models
Research highlights: Targeted Protein Degradation in Tauopathies
-1.png)
The status of drug discovery and development for Parkinson's disease
ALS Pathology and Drug Targets Using In Vitro iPSC Models
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
